orantinib has been researched along with c 1368 in 1 studies
| Studies (orantinib) | Trials (orantinib) | Recent Studies (post-2010) (orantinib) | Studies (c 1368) | Trials (c 1368) | Recent Studies (post-2010) (c 1368) |
|---|---|---|---|---|---|
| 110 | 19 | 36 | 6 | 0 | 4 |
| Protein | Taxonomy | orantinib (IC50) | c 1368 (IC50) |
|---|---|---|---|
| Chain A, Serine/threonine-protein kinase 6 | Homo sapiens (human) | 0.042 | |
| Aurora kinase A | Homo sapiens (human) | 0.042 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 0.131 | |
| Insulin-like growth factor 1 receptor | Homo sapiens (human) | 0.591 | |
| Tyrosine-protein kinase SYK | Homo sapiens (human) | 0.887 | |
| Cytoplasmic tyrosine-protein kinase BMX | Homo sapiens (human) | 0.386 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatt, HG; Borisa, AC | 1 |
1 review(s) available for orantinib and c 1368
| Article | Year |
|---|---|
A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies.
Topics: Animals; Antineoplastic Agents; Aurora Kinases; Cell Proliferation; Clinical Trials as Topic; Humans; Molecular Structure; Protein Kinase Inhibitors; Small Molecule Libraries | 2017 |